Literature DB >> 7546908

Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil.

R Ishak1, W J Harrington, V N Azevedo, N Eiraku, M O Ishak, J F Guerreiro, S B Santos, T Kubo, C Monken, S Alexander.   

Abstract

Human T cell lymphotropic virus type II (HTLV-II) infection is endemic in a number of indigenous populations in North, Central, and South America. In the present study we have employed serological and molecular methods to identify HTLV-II infection in Indian communities in the Amazon region of Brazil. Sera (1324) from 25 different Indian communities were analyzed by ELISA and Western blot. One hundred and four samples (7.8%) from a number of culturally distinct and geographically unrelated populations were found to have reactivities consistent with HTLV-II infection. Of these, 67 were from the Kayapo Indian communities, which had an overall seroprevalence rate of greater than 30%. In addition, high seroprevalence rates were observed in three other communities, the Munduruku, Arara do Laranjal and the Tyrio, suggesting that there are additional foci of endemic infection in the Amazon region. In the Kayapo, seroprevalence rates tended to increase with age, supporting the importance of sexual transmission of the virus, and family studies demonstrated that vertical transmission is also an important route of infection. Restriction fragment length polymorphism (RFLP) and nucleotide sequence analysis of a region of the env gene demonstrated that the Kayapo are infected with the HTLV-IIa subtype. Moreover, nucleotide sequence analysis of the LTR demonstrated that this belonged to a distinct HTLV-IIa phylogenetic group. The identification of HTLV-IIa in the Kayapo is, as far as we are aware, the first identified endemic focus of infection by this subtype of HTLV-II in the Americas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546908     DOI: 10.1089/aid.1995.11.813

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  33 in total

1.  Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors:  R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

2.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Epidemiological and molecular profile of blood donors infected with HTLV-1/2 in the state of Pará, northern Brazil.

Authors:  Carolina de Alcantara Maneschy; Katarine Antonia Dos Santos Barile; Jairo Augusto Américo de Castro; Maurício Koury Palmeira; Renata Bezerra Hermes de Castro; Carlos Eduardo de Melo Amaral
Journal:  Braz J Microbiol       Date:  2021-09-09       Impact factor: 2.214

4.  Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study.

Authors:  Mauricio Cristiano Rocha-Junior; Evandra Strazza Rodrigues; Svetoslav Nanev Slavov; Tatiane Assone; Maíra Pedreschi; Debora Glenda Lima de La Roque; Maisa Sousa; Viviana Olavarria; Bernardo Galvão-Castro; Benedito Antonio Lopes da Fonseca; Augusto César Penalva de Oliveira; Jerusa Smid; Oswaldo Massaiti Takayanagui; Jorge Casseb; Dimas Tadeu Covas; Simone Kashima
Journal:  Front Med (Lausanne)       Date:  2022-06-09

5.  Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-11       Impact factor: 2.205

6.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 7.  Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas.

Authors:  Arthur Paiva; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

Review 8.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

9.  Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection.

Authors:  Carlos Araujo da Costa; Karen Cristini Yumi Ogawa Furtado; Louise de Souza Canto Ferreira; Danilo de Souza Almeida; Alexandre da Costa Linhares; Ricardo Ishak; Antonio Carlos Rosário Vallinoto; José Alexandre Rodrigues de Lemos; Luisa Caricio Martins; Edna Aoba Yassui Ishikawa; Rita Catarina Medeiros de Sousa; Maísa Silva de Sousa
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

10.  Prevalence and genetic characterisation of HTLV-1 and 2 dual infections in patients with pulmonary tuberculosis in Central-West Brazil.

Authors:  Aline Garcia Kozlowski; Megmar Aparecida dos Santos Carneiro; Márcia Alves Dias de Matos; Sheila Araújo Teles; João Alves Filho Araújo; Koko Otsuki; Ana Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.